Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.
This settlement is closed!
Please see what other class action settlements you might qualify to claim cash from in our Open Settlements directory!
Canadian consumers who used Dr. Norman Barwin’s services or were affected by his services in Ontario may be eligible to receive a significant amount of compensation thanks to a recent wrongful insemination class action lawsuit settlement.
Settlement Class Members make up three Classes.
The first settlement Class — the Mother Class — includes all Canadian mothers who received artificial insemination services from Barwin or at another clinic that used semen from Barwin’s clinic in Canada between July 1973 and 2012.
The second Class, also known as the Spouse/Partner/Former Patient Class, includes individuals who were either the partner or spouse of a Mother Class Member at the time of the artificial insemination procedure. These Class Members agreed to either use a specified donor semen or have their own semen used in the procedure, but the biological father of the future child did not match up to the agreement terms. This Class also includes all Canadians who provided semen to Barwin or his clinics that was later used without patient consent.
The final Class, the Child Class, includes all children who were born as a result of the artificial insemination and whose biological father isn’t who the parents consented to.
In the class action lawsuit, plaintiffs allege Barwin was reckless in his handling of semen samples. Due to mishandling semen samples, children were later born with different biological fathers than consented to in the agreement between the patients and the doctor. Barwin allegedly is the biological father of some of the children in the case.
The defendant has not admitted liability in this situation, and the Courts have not made a determination of guilt. Both the defendant and plaintiffs believe the proposed settlement agreement is in their best interests.
As outlined in the wrongful insemination class action settlement, Class Members are eligible to receive compensation from a $13.375 million settlement fund.
The exact amount each Class Member is eligible to receive depends on which Class they are a part of and which Harm Category they fall under.
Mother and Spouse Class Members who suffered the greatest harm may claim up to $50,000.
Children who suffered the greatest harm may claim up to $40,000.
The approval hearing was held Nov. 1, 2021.
The deadline for Class Members to opt out of the Barwin wrongful insemination settlement has passed.
The deadline to find a DNA match for personal reasons or in order to pursue a claim in this settlement is Feb. 15, 2022.
The deadline to file a claim is Feb. 28, 2022.
Who’s Eligible
Class Members make up three Classes.
The first settlement Class — the Mother Class — includes all Canadian mothers who received artificial insemination services from Barwin or at another clinic that used semen from Barwin’s clinic in Canada between July 1973 and 2012.
The second Class, also known as the Spouse/Partner/Former Patient Class, includes individuals who were either the partner or spouse of a Mother Class Member at the time of the artificial insemination procedure. These Class Members agreed to either use a specified donor semen or have their own semen used in the procedure, but the biological father of the future child did not match up to the agreement terms. This Class also includes all Canadians who provided semen to Barwin or his clinics that was later used without patient consent.
The final Class, the Child Class, includes all children who were born as a result of the artificial insemination and whose biological father isn’t who the parents consented to.
Potential Award
Up to $50,000
Proof of Purchase
In most instances, Class Members will be required to have an Orchid Pro DNA test. Many already have these tests and have no follow-up currently required.
If a potential Class Member has not yet obtained this test, they should consider participating in the DNA database or otherwise following up with Class Counsel to determine whether the explanation of why they do not have the DNA test in support of their application will be sufficient.
Claim Forms
NOTE: If you do not qualify for this settlement do NOT file a claim.
Remember: you are submitting your claim under penalty of perjury. You are also harming other eligible Class Members by submitting a fraudulent claim. If you’re unsure if you qualify, please read the FAQ section of the Settlement Administrator’s website to ensure you meet all standards (Top Class Actions is not a Settlement Administrator). If you don’t qualify for this settlement, check out our database of other open class action settlements you may be eligible for.
Claim Form Deadline
02/28/2022
Case Name
Daniel Dixon, et al. v. Dr. Norman Barwin, Court File. No.: 16-70454CP, filed in the Ontario Superior Court of Justice (Ottawa Registry)
Final Hearing
11/01/2021
Settlement Website
Claims Administrator
RicePoint Administration Inc.
P.O. Box 4454, Toronto Station A
25 The Esplanade
Toronto, ON M5W 4B1
barwinclassaction@ricepoint.com
866-753-2594
Class Counsel
Peter Cronyn
Jessica Fullerton
Frances Shapiro Munn
NELLIGAN O’BRIEN PAYNE LLP
Defense Counsel
Karen Hamway
Stephanie Pearce
GOWLING WLG LLP
Read About More Class Action Lawsuits & Class Action Settlements:
- Canadian BSC Transvaginal Mesh Settlement
- Defrauded Indigenous Foster Children Class Action Settlement
- $28M Federal Administrative Segregation Class Action Settlement
- Frères du Sacré-Coeur Sexual Abuse $60M Class Action Settlement
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2024 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.